Somatic mutations in chromatin remodeler genes could modify the epigenomic landscape of CLL, but they are unheard of in this malignancy when compared with other lymphoid neoplasms. CHD2 Despite all recent therapeutic advances, a proportion of people will however fall short to reply and will be co